Table 3.
Clinical and demographic variables in C-TLE and A-TLE.
| C-TLE (N = 37) | A-TLE (N = 45) | Stat. | Sig. | |
|---|---|---|---|---|
| Age | 32.46(±13.617) | 38.64(±11.798) | −2.203 t | 0.030* |
| Sex (f/m) | 24/13 | 20/25 | 3.405X | 0.065 |
| Education (y) | 12.97(±1.724) | 13.58(±2.179) | −1.371 t | 0.174 |
| ICV (mm3) | 979131.730(±113650.017) | 1000420.270(±115629.576) | −0.836 t | 0.406 |
| TBV (mm3) | 1114386.657(±127360.941) | 1140873.702(±129184.149) | −0.930 t | 0.355 |
| HS (yes/no) | 27/10 | 20/25 | 6.755X | 0.009** |
| Age of epilepsy onset (y) | 8.30(±6.235) | 30.93(±10.391) | −11.633 t | <0.001*** |
| Epilepsy duration (y) | 24.16(±15.645) | 7.71(±6.808) | 6.365 t | <0.001*** |
| ASMs (mono/poly) | 2.30(±0.909) | 2.31(±0.925) | −0.068 t | 0.946 |
Data are presented in means (±standard deviations). y: years, ICV: intracranial volume, TBV: total brain volume, HS: hippocampal sclerosis, ASM: anti-seizure medication. t: independent sample t-test, X: Chi-squared test, *: p <.05, **: p <.01, ***: p <.001.